Lean raman imaging for rapid assessment of homogeneity in pharmaceutical formulations

Applied Spectroscopy

Volumn 64, Issue 4, 2010, Pages 442-447

  Brown, Stephanie C ^a   Claybourn, Mike ^a   Sievwright, Dawn ^a   Fearnside, Vicki ^a   Ashman, Chris ^a  

^a ASTRAZENECA   (United Kingdom)

Author keywords

Formulation; Homogeneity; Imaging; Lean; Pharmaceutical; Raman

Indexed keywords

CHEMICAL ANALYSIS; CHEMICAL STABILITY; DATA HANDLING; DISSOLUTION; DRUG PRODUCTS; IMAGING TECHNIQUES; MAPPING; MATRIX ALGEBRA; PHASE SEPARATION; SOLUBILITY; STATISTICAL METHODS;

ACTIVE PHARMACEUTICAL INGREDIENTS; FORMULATION; HOMOGENEITY; LEAN; PHARMACEUTICAL FORMULATION; PHARMACEUTICAL INDUSTRY; PHYSICAL CHARACTERISTICS; RAMAN;

MULTIVARIANT ANALYSIS;

EID: 77952369029     PISSN: 00037028     EISSN: None     Source Type: Journal    
DOI: 10.1366/000370210791114239     Document Type: Article

References (27)

1. D. Q. M. Craig, Int. J. Pharm. 231, 131 (2002).
2. K. Schamp, S. A. Schreder, and J. Dressman, Eur. J. Pharm. Biopharm. 62, 227 (2006).
3. S. A. Barker, S. P. Yap, K. H. Yuen, C. P. McCoy, J. R. Murphy, and D. Q. M. Craig, J. Controlled Release 91, 477 (2003).
4. S. Ren, M. J. Park, H. Sah, and B. J. Lee, Int. J. Pharm. 350, 197 (2008).
5. O. Chambin and V. Jannin, Drug Devel. Indust Pharm. 31, 527 (2005).
6. F. Damian, N. Blaton, L. Naesens, J. Balzarini, R. Kinget P. Augustijns, and G. Van den Mooter, Eur. J. Pharm. Sci. 10, 311 (2000).
7. S. K. Dordunoo, J. L. Ford, and M. H. Rubinstein, Drug Devel. Indust. Pharm. 17, 685 (1991).
8. M. S. Saygili, G. Uzunkaya, Y. Ozsoy, and A. Araman, Sci. Pharm. 70, 295 (2002).
9. S. Hulsmann, T. Backensfeld, S. Keitel, and R. Bodmeier, Eur. J. Pharm. Biopharm. 49, 237 (2000).
10. F. Damian, N. Blaton, L. Naesens, J. Balzarini, R. Kinget, P. Augustijns, and G. Van den Mooter, Eur. J. Pharm. Sci. 10, 311 (2000).
11. O. Chambin, V. Jannin, D. Champion, C. Chevalier, M. H. RochatGonthier, and Y. Pourcelot, Int J. Pharm. 278, 79 (2004).
12. A. Svensson, C. Neves, and B. Cabane, Int. J. Pharm. 281, 107 (2004).
13. N. Shah, W. Phuapradit, and H. Ahmed, Am. Pharm. Rev. 6, 14 (2003).
14. S. K. Dordunoo, J. L. Ford, and M. H. Rubinstein, J. Pharm. Pharm. 48, 782 (1996).
15. F. C Clarke, M. J. Jamieson, D. A. Clark, S. V. Hammond, R. D. Jee, and A. C Moffat, Anal. Chem. 73, 2213 (2001).
16. S. Sasic, Anal. Chim. Acta 611, 73 (2008).
17. S. Sasic, Appl. Spectrosc. 61, 239 (2007).
18. E. Lee, W. X. Huang, P. Chen, E. N. Lewis, and R. V. Vivilecchia, Spectroscopy 21(11), 24 (2006).
19. F. Clarke, Vib. Spectrosc. 34, 25 (2004).
20. R. C. Lyon, D. S. Lester, E. N. Lewis, E. Lee, L. X. Yu, E. H. Jefferson, and A. Hussain, SAAPS Pharm. Sci. Technol. 3, 3 (2002).
21. S. Sasic and D. A. Clark, Appl. Spectrosc. 60, 494 (2006).
22. W. O. Lin, J. H. Jiang, H. F. Yang, Y. Ozaki, G. L. Shen, and R. O. Yu, Anal. Chem. 78, 6003 (2006).
23. J. Breitenbach, W. Schrof, and J. Neumann, Pharm. Res. 16, 1109 (1999).
24. S. Sasic, D. A. Clark, J. C Mitchell, and M. J. Snowden, Analyst (Cambridge, U.K.) 129, 1001 (2004).
25. L. Zhang, M. J. Henson, and S. S. Sekulic, Anal. Chim. Acta 545, 262 (2005).
26. J. A. Timlin, A. Carden, and M. D. Morris, Appl. Spectrosc. 53, 1429 (1999).
27. D. J. Wheeler and D. S. Chambers, Understanding Statistical Process Control (SPC Press, KnoxviUe, Tennessee, 1992), 2nd ed.. Chap. 3.4-3.6, pp. 46-50, Table A.3, p. 395.